JOHNSON & JOHNSON JNJ

Healthcare Biotechnology

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).

NYSE:JNJ - Post by User

JOHNSON & JOHNSON

<< Previous

Bullboard Posts

Next >>

Post by cmarketinsightson Dec 10, 2024 4:05pm

20 Views

Post# 36355341

Rate cuts are pulling attention toward growth sectors

Hi J&J followers!

Rate cuts are pulling attention toward growth sectors, but what does this mean for healthcare giants like J&J? Explore Analysts' Ideas of the Week to understand the dynamics at play: https://www.researchfrc.com/content/analyst-ideas/post/182/the-week-of-rate-cuts-whats-at-stake-for-investorshttps://www.researchfrc.com/content/analyst-ideas/post/182/the-week-of-rate-cuts-whats-at-stake-for-investors

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features